1. Home
  2. SCLX vs GNS Comparison

SCLX vs GNS Comparison

Compare SCLX & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$4.90

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Logo Genius Group Limited

GNS

Genius Group Limited

N/A

Current Price

$0.15

Market Cap

32.1M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
GNS
Founded
2011
2002
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
32.1M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SCLX
GNS
Price
$4.90
$0.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
36.4K
3.1M
Earning Date
04-10-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,253,000.00
N/A
Revenue This Year
$122.52
$156.26
Revenue Next Year
$186.30
$35.38
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.15
52 Week High
$34.27
$1.06

Technical Indicators

Market Signals
Indicator
SCLX
GNS
Relative Strength Index (RSI) 27.24 39.29
Support Level $4.20 $0.15
Resistance Level $7.77 $0.23
Average True Range (ATR) 0.30 0.01
MACD 0.01 -0.00
Stochastic Oscillator 5.93 1.04

Price Performance

Historical Comparison
SCLX
GNS

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About GNS Genius Group Limited

Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. Its revenue is derived from five reportable segments: Central, Academy, School, Resorts, and Discontinued operations. Geographically, it operates in Europe/Middle East/Africa, Asia/Pacific, and North America/South America.

Share on Social Networks: